PHILADELPHIA, July 23, 2014 /PRNewswire/ --
Doctor Evidence to provide a
comprehensive clinical evidence platform to support Elsevier
Clinical Solutions' global clinical product suite
Elsevier, a world-leading provider of scientific, technical and
medical information products and services, announced today that
Elsevier Clinical Solutions' Evidence-based Medicine Center (EBM
Center) has reached an agreement with Doctor Evidence LLC (DRE) to
provide the platform engine supporting the Clinical Solutions'
suite of evidence-based clinical solutions.
"Doctor Evidence is tremendously excited to be working with the
Elsevier EBM Center in providing physicians and patients with truly
evidence-based clinical data," said Robert
Battista, CEO and Co-Founder of Doctor Evidence. "Consistent
with our company values, the most gratifying partnerships are the
ones that have the potential to directly impact patients and
improve their outcomes and well-being through the use of evidence.
This engagement with the Elsevier EBM Center is one of those
partnerships."
DRE will configure databases with high quality data from the
medical literature pertinent to key clinical topics for the EBM
Center, assuring that all the information is reliably and easily
managed through a robust technology platform that is compliant with
the standards set forth by the world's leading authorities on
evidence-based medicine. DRE's Digital Outcome Conversion (DOC™)
suite of products will provide the evidence foundation supporting
Elsevier solutions such as ClinicalKey, InOrder by Elsevier, and
other point-of-care decision support resources.
"Our suite of clinical solutions addresses some of the biggest
challenges in healthcare by making clinical evidence available to
professionals and patients at the right time and in the right
setting," said David Goldmann, MD,
Vice President and Chief Medical Quality Assurance Officer at
Elsevier Clinical Solutions. Goldmann heads up the EBM Center.
"The EBM Center is charged with ensuring that Elsevier's
clinical content is as high-quality and evidence-based as it can
be. Among the many companies claiming to be able to meet our needs
for extracting and synthesizing clinical data to support our
activities, Doctor Evidence stands alone with its combination of
people, process and technology," Goldmann said. "Doctor Evidence's
platform will allow our team of methodologists and subject matter
experts to conduct powerful analyses and to continually update the
body of evidence supporting our clinical products."
About Doctor Evidence, LLC
Doctor Evidence is a specialty software platform and services
company aimed to assist stakeholders across the healthcare
ecosystem to make and inform clinical decisions with the most
relevant medical evidence. The Doctor Evidence methodology uses a
Digital Outcome Conversion (DOC™) approach of taking data from
static sources and to transform it into reusable, dynamic
databases. The Doctor Evidence software platform empowers both
public and private sector clients via programs like its GROWTH
Collaborative.
About Elsevier
Elsevier is a world-leading provider of information solutions
that enhance the performance of science, health, and technology
professionals, empowering them to make better decisions, deliver
better care, and sometimes make groundbreaking discoveries that
advance the boundaries of knowledge and human progress. Elsevier
provides web-based, digital solutions - among them
ScienceDirect, Scopus, Elsevier Research Intelligence and
ClinicalKey - and publishes nearly 2,200 journals, including The
Lancet and Cell, and over 25,000 book titles, including
a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world-leading
provider of professional information solutions in the Science,
Medical, Legal and Risk and Business sectors, which is jointly
owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols
are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).
Media contact
Christopher Capot
Director, Corporate Relations
Elsevier
+1-212-633-3164
c.capot@elsevier.com
SOURCE Elsevier